Ameritas Investment Partners, Inc. Abb Vie Inc. Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 55,327 shares of ABBV stock, worth $9.96 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

55,327

Previous 58,088 4.75%

Holding current value

$9.96 Million

Previous $9.96 Million 9.66%

% of portfolio

0.37%

Previous 0.35%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $452,362 - $550,350	-2,761 Reduced 4.75%	55,327 $10.9 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $5,572 - $6,507	-36 Reduced 0.06%	58,088 $9.96 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $650,787 - $741,511	-4,072 Reduced 6.55%	58,124 $10.6 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $781,705 - $880,384	5,681 Added 10.05%	62,196 $9.64 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $671,289 - $777,116	5,025 Added 9.76%	56,515 $8.42 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $738,478 - $918,987	5,573 Added 12.14%	51,490 $6.94 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $65,942 - $75,942	456 Added 1.0%	45,917 $7.32 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $1.44 Million - $1.73 Million	10,442 Added 29.82%	45,461 $7.35 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $46,570 - $53,413	347 Added 1.0%	35,019 $4.7 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $56,837 - $72,258	-413 Reduced 1.18%	34,672 $5.31 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $420,752 - $522,035	-3,188 Reduced 8.33%	35,085 $5.69 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $115,057 - $145,581	1,071 Added 2.88%	38,273 $5.18 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $32,132 - $36,475	-302 Reduced 0.81%	37,202 $4.01 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $102,474 - $114,162	974 Added 2.67%	37,504 $4.22 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $143,424 - $157,893	-1,402 Reduced 3.7%	36,530 $3.94 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $418,869 - $565,518	5,204 Added 15.9%	37,932 $4.06 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $164,088 - $192,585	-1,910 Reduced 5.51%	32,728 $2.87 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $27,367 - $36,621	-373 Reduced 1.07%	34,638 $3.4 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $31,992 - $48,503	-496 Reduced 1.4%	35,011 $2.67 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $624,285 - $781,113	-8,655 Reduced 19.6%	35,507 $3.14 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1.31 Million - $1.58 Million	-20,853 Reduced 32.07%	44,162 $3.34 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $14,191 - $18,139	-216 Reduced 0.33%	65,015 $4.73 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $100,821 - $118,662	-1,307 Reduced 1.96%	65,231 $5.26 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $46,242 - $57,029	-594 Reduced 0.88%	66,538 $6.13 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $65,971 - $73,339	-742 Reduced 1.09%	67,132 $6.35 Million
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $611,132 - $723,107	6,807 Added 11.15%	67,874 $6.29 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $1.61 Million - $2.16 Million	17,532 Added 40.27%	61,067 $5.78 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $185,657 - $203,589	2,073 Added 5.0%	43,535 $4.18 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $9,779 - $12,490	140 Added 0.34%	41,462 $3.19 Million
Q2 2017 Aug 15, 2017	BUY	N/A	41,322	41,322 $3 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Abb Vie Inc. Transaction History